Methods This systematic review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [8]
Research backs this up: when using GLP-1s to aid in weight loss, they were found to effectively reduce BMI, triglycerides, waist circumference, and total testosterone in people with PCOS, according to a 2024 meta-analysis in the Journal of Diabetes and its Complications
Clinical studies in humans have not been published so far (41, 51)
Ironically, it is the unprecedented success of these medications that has the team worried
Tirzepatide targets both GLP-1 and GIP receptor pathways simultaneously
Contact TorHoerman Law or use the chatbot on this page to find out if you qualify for the Ozempic Lawsuit